Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K991970
    Manufacturer
    Date Cleared
    1999-10-25

    (136 days)

    Product Code
    Regulation Number
    878.4025
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    ScarEase Sheets and Gel are indicated for use in the management of hypertrophic and keloid scars. ScarEase Sheets and Gel may prevent hypertrophic and keloid scarring.

    Device Description

    ScarEase is a non-invasive medical device that reduces hypertrophic and keloid scars resulting from surgical procedures and traumatic events. ScarEase may soften, smooth and/or flatten scars. ScarEase Sheets will be individually packaged rectangular-shaped sheets (.0055 to .040″ thickness, by 1.5″ wide, by 4.0″ long) heat-sealed in polyethylene tubing, enclosed in a fold-over (labeled) outer covering with descriptive product information, enclosed with a package insert and sealed with shrinkwrap. ScarEase Gel will be available in 4 and 15 gram tamper-evident, labeled tubes. Each tube will be appropriately labeled to provide size, instructions for use and warnings. Each tube is generally placed into a descriptive display box stating product information and enclosed with a package insert. ScarEase sheets are made from Applied Silicone's calendared silicone sheeting material, durometer 50, shore A. ScarEase Gel is an amorphous clear gel made with Nusil Technology's MED 4210 4211 infused with polydimethysiloxane and silicone dioxide.

    AI/ML Overview

    The provided text is a 510(k) summary for the device "ScarEase Sheets and ScarEase Gel," which describes the product, its intended use, and its substantial equivalence to predicate devices. However, this document does not contain any information about acceptance criteria, device performance studies, sample sizes, ground truth establishment, or multi-reader multi-case (MRMC) studies.

    The purpose of a 510(k) summary is to demonstrate that a new device is "substantially equivalent" to a legally marketed predicate device. This typically involves demonstrating similar technological characteristics and intended use, rather than presenting a detailed clinical study with performance metrics against pre-defined acceptance criteria.

    Therefore, I cannot fulfill your request for the specific information regarding acceptance criteria and study details based on the provided text. The document focuses on demonstrating equivalence to existing devices based on materials and intended use.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1